Received Feb 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
"sore arms"; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY ("sore arms") in a 60-year-old female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. Concurrent medical conditions included Diabetes. On 04-Feb-2025, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form. On 05-Feb-2025, after starting mRNA-1273.712 (SPIKEVAX 2024-2025 PFS), the patient experienced PAIN IN EXTREMITY ("sore arms"). At the time of the report, PAIN IN EXTREMITY ("sore arms") outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2025, Blood glucose increased: high blood sugar of 185. No concomitant medication was reported. No treatment information was reported. This case was linked to US-MODERNATX, INC.-MOD-2025-782124 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-782124:mRESVIA RSV Vaccine
Diabetes
Test Date: 20250205; Test Name: Blood sugar; Result Unstructured Data: high blood sugar of 185